OL
Healthcare & Life Sciences
Oculgen Biomedical Technology Co., Ltd
Chinawww.oculgen.com/
Oculgen Biomedical Technology Co., Ltd is a Healthcare & Life Sciences startup based in China, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Oculgen Biomedical Technology Co., Ltd
Oculgen Biomedical Technology Co., Ltd is a company headquartered in China. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Oculgen develops macromolecular ophthalmic drugs focused on innovative treatments for fundus and retinal diseases, including neovascular age-related macular degeneration and diabetic retinal conditions, progressing through early discovery to clinical trials in China and the US.
Explore Oculgen Biomedical Technology Co., Ltd's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.